[1] KIENREICH K,TOMASCHITZ A,VERHEYEN N,et al. Vitamin D and cardiovascular disease[J]. Nutrients, 2013, 5(8):3005-3021. [2] PETCHEY WG, HOWDEN EJ, JOHNSON DW, et al. Cardiorespiratory fitness is independently associated with 25-hydroxyvitamin D in chronic kidney disease[J]. Clin J Am Soc Nephrol, 2011, 6(3):512-518. [3] 江巍,高凤荣. 维生素D缺乏相关性疾病研究进展[J]. 中国骨质疏松,2014, 20(3):331-335. [4] RAVANI P, MALBERTI F, TRIPEPI G, et al. Vitamin D levels and patient outcome in chronic kidney diseases[J]. Kidney Int, 2009, 75(1):88-95. [5] GRANT WB. Differences in 25-hydroxyvitamin D concentrations may explain the black-white differences in chronic kidney disease and risk of renal cell carcinoma[J]. Epidemiology, 2015, 26(4):e48-e49. [6] 刘宁, 叶小珍, 卢斌, 等. 初诊2型糖尿病患者血清25-羟维生素D水平与胰岛α细胞及β细胞功能的相关性[J]. 医学研究生学报, 2016, 29(1):57-61. [7] 王菊, 王海燕,张桂霞,等. 慢性肾脏病患者血清25-羟维生素D水平及其影响因素分析[J]. 安徽医科大学学报, 2016, 51(1):106-108. [8] CANKAYA E, BILEN Y, KELES M, et al. Comparison of serum vitamin D levels among patients with chronic kidney disease, patients in dialysis, and renal transplant patients[J]. Transplant proc, 2015,47(5):1405-1407. [9] SATIRAPOJ B, LIMWANNATA P, CHAIPRASERT A, et al. Vitamin D insufficiency and deficiency with stages of chronic kidney disease in an Asian population[J]. BMC Nephrol, 2013,14:206 [10] 吕轶伦,林颍,史浩,等.慢性肾脏病患者维生素D不足与缺乏[J].中华肾脏病杂志,2009,25(9):668-672. [11] CACCAMO D, RICCA S, CURRO M, et al. Health risks of hypovitaminosis D:A review of new molecular insight[J]. Int J Mol Sci, 2018, 19(3):892. [12] LIM L L, NG Y M, KANG P S, et al. Association between serum 25-hydroxyvitamin D and glycated hemoglobin levels in type 2 diabetes patients with chronic kidney disease[J]. J Diabetes Investig, 2017, 9(2):375-382. [13] 周晓霜, 李荣山. 慢性肾脏病患者维生素D缺乏的风险因素分析[J]. 中国药物与临床, 2017, 17(7):1054-1056. [14] 李铎, 卞维静, 张凌. 慢性肾脏病的流行病学及维与生素D的缺乏[J]. 临床药物治疗杂志, 2012, 10(1):12-14. [15] LV Y, LIN Y, SHI H, et al. Vitamin D insufficiency and deficiency in chronic kidney disease patients[J]. Chin J Nephrol, 2009, 25(9):668-672. [16] NG Y M, LIM S K, KANG P S, et al. Association between serum 25-hydroxyvitamin D levels and carotid atherosclerosis in chronic kidney disease patients[J]. BMC Nephrol, 2016, 17(1):151. [17] PATEL N M, GUTIERREZ O M, ANDRESS D L, et al. Vitamin D deficiency and anemia in early chronic kidney disease[J]. Kidney Int, 2010, 77(8):715-720. [18] 滕兰波, 常明, 刘书馨, 等. 维持性血液透析患者血25羟维生素D缺乏对肾性贫血的影响[J]. 中国老年学杂志, 2012, 32(20):4554-4555. [19] KENDRICK J, TARGHER G, SMITS G, et al. 25-Hydroxyvitamin D deficiency and inflammation and their association with hemoglobin levels in chronic kidney disease[J]. Am J Nephrol, 2009, 30(1):64-72. [20] XU L, ZHANG P, GUAN H, et al. Vitamin D and its receptor regulate lipopolysaccharide-induced transforming growth factor-β,angiotensinogen expression and podocytes apoptosis through the nuclear factor-κB pathway[J]. J Diabetes Investi, 2016, 7(5):680-688. [21] RAI P, SINGH T, LEDERMAN R, et al. Hyperglycemia enhances kidney cell injury in HIVAN through down-regulation of vitamin D receptors[J]. Cell Signal, 2015, 27(3):460-469. [22] 王雪,李英.维生素D延缓糖尿病肾病的研究进展[J].临床荟萃, 2018, 33(3):267-270. [23] HAMZAWY M, SAA G, RASHID L, et al. The cellular selection between apoptosis and autophagy:roles of vitamin D, glucose and immune response in diabetic nephropathy[J]. Endocrine, 2017, 58(1):66-80. |